The BrainChip Holdings Ltd (ASX: BRN) share price is in focus today after the company reported a cash balance of US$20.3 million at 30 June 2026, and moved into commercial production of its AKD1500 neuromorphic AI chip.
Image source: Getty Images
What did BrainChip report?
- Quarter-end cash balance: US$20.3 million (down from US$25.3 million last quarter)
- First production batch of 2,000 AKD1500 chips received, kicking off commercial manufacturing
- Commercial delivery of Akida 2.0 IP design assets to EDGEAI
- Net operating cash outflow: US$4.7 million for the quarter (improved from US$5.3 million last quarter)
- Expiration of LDA Capital Put Option Facility, with A$1.0 million Failure Fee settled
What else do investors need to know?
BrainChip shifted from pre-production to commercial-scale manufacturing, with the first AKD1500 units ready for customer deployment across defence, industrial, and edge AI markets. Further shipments are due in Q3 as production scales toward a run of about 60,000 chips, though initial yields were a bit lower than expected.
The company saw the expiry of its Put Option Agreement with LDA Capital. The associated A$1.0 million contractual obligation was settled by LDA selling collateral shares, resolving outstanding arrangements. BrainChip expects to update the market once remaining collateral shares are disposed of and net funds remitted.
On the technology front, BrainChip is investing in a range of hardware form factors—like M.2 and PCIe accelerator cards, Raspberry Pi boards, and reference platforms—to accelerate customer adoption of its AKD1500 chip. The AKD2500 project and a Generative AI platform also remain on track.
What's next for BrainChip Holdings?
BrainChip is set to dispatch additional AKD1500 units through the next quarter, supporting customer pilots and expanding commercial reach. Management expects these ready-to-use hardware platforms to lower integration barriers, shorten sales cycles, and build recurring revenue from silicon sales and IP licensing.
Longer term, BrainChip is advancing its AKD2500 and Generative AI projects, while expanding its ecosystem of software partners and licensed technology customers. The company aims to capture growing demand for low-power, edge-based artificial intelligence solutions.
BrainChip Holdings share price snapshot
Over the past 12 months, BrainChip shares have declined 45%, trailing the All Ordinaries Index (ASX: XAO), which is flat over the same period.
